We are live on ! Find out more
KALA icon

KALA BIO
KALA

63 hedge funds and large institutions have $2.27M invested in KALA BIO in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 22 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

875% more call options, than puts

Call options by funds: $39K | Put options by funds: $4K

0.01% less ownership

Funds ownership: 0.01% → 0% (-0.01%)

23% less funds holding

Funds holding: 82 → 63 (-19)

55% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 22

58% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 26

93% less capital invested

Capital invested by funds: $33.7M → $2.27M (-$31.4M)

Holders
63
Holders Change
-19
Holders Change %
-23.17%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
10
Reduced
22
Closed
26
Calls
$39K
Puts
$4K
Net Calls
+$35K
Net Calls Change
+$128K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$328K
2
E
Ergoteles
New York
+$138K
3
Goldman Sachs
Goldman Sachs
New York
+$97.3K
4
Citadel Advisors
Citadel Advisors
Florida
+$59.6K
5
Renaissance Technologies
Renaissance Technologies
New York
+$58.1K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$15M
2
BlackRock
BlackRock
New York
-$1.47M
3
GL
Graypoint LLC
New York
-$672K
4
State Street
State Street
Massachusetts
-$604K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$319K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$11K -$29.8K -19 -56%
MC
27
Matisse Capital
Oregon
$11K – – –
HF
28
HRT Financial
New York
$11K +$25.1K +16 New
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
$9K +$20.4K +13 New
GWM
30
Greenwich Wealth Management
Connecticut
$8K +$3.14K +2 +22%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$6K -$83.2K -53 -87%
Group One Trading
32
Group One Trading
Illinois
$6K -$3.14K -2 -20%
CLOS
33
Compagnie Lombard Odier SCmA
Switzerland
$6K – – –
CAG
34
Csenge Advisory Group
Florida
$6K – – –
WS
35
Wedbush Securities
California
$6K – – –
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$5K -$72.2K -46 -88%
Citigroup
37
Citigroup
New York
$5K -$4.71K -3 -33%
Squarepoint
38
Squarepoint
New York
$5K +$9.41K +6 New
GCP
39
GSA Capital Partners
United Kingdom
$4K -$9.41K -6 -55%
C
40
Covestor
United Kingdom
$4K -$1.57K -1 -17%
IIA
41
IPG Investment Advisors
California
$4K – – –
Osaic Holdings
42
Osaic Holdings
Arizona
$4K – – –
ACM
43
Aquatic Capital Management
Illinois
$4K +$7.84K +5 New
PGFC
44
Peapack-Gladstone Financial Corp
New Jersey
$4K +$7.84K +5 New
Creative Planning
45
Creative Planning
Kansas
$4K +$9.41K +6 New
VPIM
46
Vanguard Personalized Indexing Management
California
$4K +$9.41K +6 New
AWA
47
Artemis Wealth Advisors
New York
$3.88K – – –
Commonwealth Equity Services
48
Commonwealth Equity Services
Massachusetts
$3K -$1.57K -1 -20%
FNBT
49
FineMark National Bank & Trust
Florida
$3K – – –
KAS
50
Kestra Advisory Services
Texas
$3K – – –
1
2
3 4

KALA Hedge Fund Activity: Q2 2022 in Review

63 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q2 2022, worth a combined $2.27M — down 93% from $33.7M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of KALA and 11 opened new positions — a net loss of 15 holders — while 22 trimmed existing stakes and 10 added.

The largest buyer was Millennium Management, adding an estimated $328K. The largest seller was RA Capital Management, exiting entirely with an estimated $15M sold.

  • 63 institutional investors held KALA BIO (KALA) as of Q2 2022, down from 82 in Q1 2022.
  • Funds reported $2.27M of KALA BIO stock for Q2 2022, down 93% quarter-over-quarter.
  • 11 funds opened new KALA BIO positions in Q2 2022 and 26 closed out, a net change of -15 holders.
  • The largest KALA BIO buyer in Q2 2022 was Millennium Management, an estimated $328K added.
  • The largest KALA BIO seller in Q2 2022 was RA Capital Management, an estimated $15M sold.

Based on aggregated 13F filings for Q2 2022.